Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
BETHESDA, Md., Dec. 12, 2012 /PRNewswire/ –Northwest Biotherapeutics, Inc. (Nasdaq: NWBO; NWBOW), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced the full exercise of the over-allotment option …
See all stories on this topic »